Results 41 to 50 of about 8,230 (180)
Psoriasis is a common skin disease with various cutaneous manifestations and is classified into two clinical groups: non-pustular and pustular. Pustular psoriasis is less common than non-pustular forms of psoriasis and is particularly resistant to ...
Sarah J.J. Touyz, Melanie Pratt
doaj
Consensus‐based Guideline on tinea capitis
Summary The consensus‐based guideline developed under the auspices of the German Dermatological Society (DDG) is intended to provide physicians with a structured framework for clinical decision‐making in the management of patients with tinea capitis and to contribute to improved diagnostic accuracy, treatment adherence, and prevention. Tinea capitis is
Peter Mayser +19 more
wiley +1 more source
Analysis of clinical and morphological features of common forms of pustular psoriasis
In recent decades, the frequency of cases of widespread forms of pustular psoriasis has significantly increased, which are often mistaken for other chronic dermatoses: eczema, bullous toxidermia, herpes, Andrews’ pustular bacterid, subcorneal pustulosis,
M. E. Zapolskyi +4 more
doaj +1 more source
The article presents the clinical observation effectiveness of TNF-a inhibitor etanercept in patients with generalized pustular psoriasis and PsA, resistant to treatment by other drugs of this class.
V. V. Vustina +2 more
doaj +1 more source
Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report
Acrodermatitis continua of Hallopeau is a rare variant of localized pustular psoriasis characterized by the recurrent eruption of sterile pustules involving the distal portions of the fingers and toes that can lead to the destruction of the nail ...
Katrina D Cirone, Fiona E Lovegrove
doaj +1 more source
Systemic Treatment and Outcome in Erythrodermic Psoriasis: A Retrospective Multicenter Study
This multicentre real‐world study illustrates the heterogeneity of systemic treatment approaches in erythrodermic psoriasis (EP) in Bavaria, Germany. Adverse events were more frequently observed with conventional therapies, whereas biologic therapies showed favorable outcomes.
Julian Kögel +15 more
wiley +1 more source
A pediatric case of dupilumab-induced pustular psoriasis
Aim: Dupilumab is a novel treatment agent for moderate to severe atopic dermatitis (AD) with few adverse effects. Drug-induced psoriasiform lesions are rare.Methods: We report a 4-year-old boy with AD who developed pustular psoriasis during treatment ...
Nan Dang, Huiwen Zheng, Yunqing Ren
doaj +1 more source
The clinical effects of selective IL‐23 inhibition in refractory pyoderma gangrenosum, highlighting progressive ulcer healing, reduction in inflammation and pain, and steroid‐sparing effect, supporting the role of the IL‐23/Th17 axis as a therapeutic target.
Luca Bettolini +25 more
wiley +1 more source
Evaluation of Discontinuation and Re‐Initiation of Biologic Therapies in Psoriasis: Real‐World Data
The cumulative probability of remaining relapse‐free following biologic therapy discontinuation was 35.6%, 19%, 11.6%, and 9.1% at 6, 12, 18, and 24 months, respectively. Prolonged relapse durations were associated with a low baseline PASI score, the presence of a PASI 90 response at discontinuation, the absence of triggering factors, and the use of IL‐
Ahmet Taha Aydemir, Nihal Kundakcı
wiley +1 more source
Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
Plaque psoriasis and pustular psoriasis are overlapping, but distinct, disorders. The therapeutic response to biologics supports the pivotal role of the tumour necrosis alpha (TNF-?)/ interleukin (IL)-23/IL-17/IL-22 axis in the pathogenesis of these ...
Kazuhisa Furue +8 more
doaj +1 more source

